GCP
VIVO

GSA Capital Partners’s Meridian Bioscience Inc VIVO Stock Holding History

GSA Capital Partners’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-40,794
Closed -$399K – 1696
2019
Q4 		$399K Sell
40,794
-7,746
-16% -$72.7K 0.05% 818
2019
Q3 		$461K Sell
48,540
-3,292
-6% -$34.7K 0.06% 606
2019
Q2 		$616K Buy
+51,832
New +$624K 0.07% 534
2019
Q1 		– Sell
-15,825
Closed -$275K – 1770
2018
Q4 		$275K Sell
15,825
-108,967
-87% -$1.86M 0.03% 880
2018
Q3 		$1.86M Sell
124,792
-14,955
-11% -$232K 0.1% 276
2018
Q2 		$2.22M Sell
139,747
-17,941
-11% -$268K 0.11% 223
2018
Q1 		$2.24M Buy
157,688
+66,838
+74% +$989K 0.12% 222
2017
Q4 		$1.27M Sell
90,850
-20,467
-18% -$300K 0.08% 450
2017
Q3 		$1.59M Buy
111,317
+19,817
+22% +$283K 0.11% 246
2017
Q2 		$1.44M Buy
+91,500
New +$1.32M 0.09% 295
2016
Q4 		– Sell
-66,132
Closed -$1.28M – 2021
2016
Q3 		$1.28M Sell
66,132
-75,758
-53% -$1.48M 0.07% 469
2016
Q2 		$2.77M Buy
141,890
+40,024
+39% +$785K 0.15% 127
2016
Q1 		$2.1M Buy
101,866
+6,494
+7% +$128K 0.13% 162
2015
Q4 		$1.96M Buy
95,372
+79,030
+484% +$1.52M 0.1% 267
2015
Q3 		$279K Sell
16,342
-19,077
-54% -$349K 0.01% 1406
2015
Q2 		$660K Sell
35,419
-26,561
-43% -$492K 0.03% 1177
2015
Q1 		$1.18M Buy
+61,980
New +$1.15M 0.05% 722
2014
Q4 		– Sell
-15,832
Closed -$280K – 1956
2014
Q3 		$280K Sell
15,832
-2,800
-15% -$55K 0.01% 1306
2014
Q2 		$385K Buy
+18,632
New +$383K 0.02% 1290
2014
Q1 		– Sell
-22,532
Closed -$598K – 1862
2013
Q4 		$598K Buy
22,532
+6,300
+39% +$155K 0.05% 712
2013
Q3 		$384K Buy
+16,232
New +$379K 0.03% 971

Other funds holding VIVO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

GSA Capital Partners's VIVO Position: Q1 2020 in Review

GSA Capital Partners sold out of Meridian Bioscience Inc (VIVO) in Q1 2020, closing a stake of 40,794 shares — an estimated $399K sold.

GSA Capital Partners first reported a position in VIVO in Q3 2013 and held it in 21 quarters. The position peaked at $2.77M in Q2 2016. 168 funds tracked by Wall St. Rank hold VIVO as of Q1 2020.

  • GSA Capital Partners reported no remaining Meridian Bioscience Inc position as of Q1 2020 after selling out during the quarter.
  • GSA Capital Partners sold 40,794 Meridian Bioscience Inc shares in Q1 2020, an estimated $399K.
  • GSA Capital Partners first reported a position in Meridian Bioscience Inc in Q3 2013 and held it in 21 quarters.
  • GSA Capital Partners's Meridian Bioscience Inc position peaked at $2.77M in Q2 2016.
  • 168 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2020.

Based on GSA Capital Partners's 13F filing for Q1 2020, filed 12 May 2020.